Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing ...

Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), announces the company will attend the 2025 EAACI Congress in Glasgow, UK, on June 13-16.

MELBOURNE, Australia and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Aravax, a clinical-stage biotechnology ...

Learn when rashes signal medical emergencies. Color, location, and symptoms reveal dangerous conditions needing urgent care.

Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Cake typically marks celebrations, but none of these cake recalls were cause for festivity. Learn about the biggest cake ...

Yet my experience is a blip among the millions of people with allergies in Australia. Around 5 million Australians live with ...

U.S. INDICATIONS AND USAGE POMBILITI in combination with OPFOLDA is indicated for the treatment of adult patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) ...

Nicotinamide N-methyltransferase (NNMT) and its metabolite 1-MNA have been implicated in liver disease and stress adaptation. Here, the authors show that NNMT/1-MNA protects against hepatic ...

If left untreated, acute HIV infection progresses to chronic HIV, which can last for decades. In chronic HIV, the virus continues to replicate and destroy CD4 cells. People may not experience ...